Latest News about REGN
Recent news which mentions REGN
Regeneron's COVID-19 Antibody Cocktail Wins EU Positive Opinion
February 26, 2021
From Benzinga
From Benzinga
From MarketWatch
Regeneron To Stop Giving Placebo In COVID-19 Antibody Trial After 'Clear Efficacy'
February 25, 2021
Tickers
REGN
From Benzinga
Decibel Therapeutics' Hearing Loss Gene Therapy Shows Potential In Preclinical Studies
February 24, 2021
From Benzinga
RLFTF: Why Little-Known Relief Therapeutics Is Climbing Today
February 24, 2021
From InvestorPlace
Opthea Outlines OPT-302 Pivotal Study Designs In Chronic Eye Disorder
February 24, 2021
From Benzinga
Why You Should Keep Your Distance from Ocugen Stock
February 23, 2021
From InvestorPlace
Sanofi/Regeneron's DUPIXENT Wins Canada Approval For Atopic Dermatitis In Children Aged 6-11
February 23, 2021
From Benzinga
2 Best Pharma Stocks to Buy Right Now
February 23, 2021
From Motley Fool
FDA Approves Regeneron/Sanofi's Libtayo For Front-Line Lung Cancer
February 23, 2021
From Benzinga
Should You Follow Cathie Wood Into This Coronavirus Stock?
February 23, 2021
From Motley Fool
Should Investors Worry About Moderna's Vaccine Delays?
February 23, 2021
From Motley Fool
What Are the Long-Term Prospects for Moderna?
February 21, 2021
From Motley Fool
3 Reasons to Buy Ocular Therapeutix Stock Right Now
February 16, 2021
From Motley Fool
Better Coronavirus Stock: Inovio Pharmaceuticals vs. Vaxart
February 15, 2021
From Motley Fool
5 Cathie Wood Stocks That Were Big ARK Invest Buys Last Week
February 15, 2021
From Motley Fool
1 Big COVID-19 Story That Has Nothing to Do With Vaccines
February 14, 2021
From Motley Fool
The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week
February 14, 2021
From Benzinga
Roche's Faricimab On Par With Rival Regeneron's Aflibercept In Four Late-Stage Studies In Vision Loss Disorder
February 12, 2021
From Benzinga
Can Coronavirus Antibodies Overcome Their Obstacles?
February 12, 2021
From Motley Fool
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
February 11, 2021
From Benzinga
4 Top COVID Stocks to Buy in February
February 11, 2021
From Motley Fool
3 Reasons Pfizer's Failures Could Lead to a Big Acquisition
February 11, 2021
From Motley Fool
3 Absurdly Cheap Coronavirus Stocks to Buy Now
February 11, 2021
From Motley Fool
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
February 10, 2021
From Benzinga
3 Best Biotech Stocks to Buy Now
February 10, 2021
From Motley Fool
Sanofi/Regeneron's Libtayo Wins FDA Approval For A Type Of Skin Cancer
February 10, 2021
From Benzinga
Eli Lilly Antibody Drug Combo For COVID-19 Gets FDA Emergency Approval
February 10, 2021
From Benzinga
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.